Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 11 | ECE2006 | Next issue

8th European Congress of Endocrinology incorporating the British Endocrine Societies

Poster Presentations

Endocrine tumours and neoplasia

Previous section
Endocrine disruptors
Table of contents
Next section
Growth and development

ea0011p437 | Endocrine tumours and neoplasia

Estrogen receptor alpha and beta (ERα and -β) gene and protein expression in breast cancer cell lines: verification by RT-PCR and Western blotting

ea0011p438 | Endocrine tumours and neoplasia

Challenges associated with the diagnosis, differential diagnosis and treatment of 4 cases of ACTH-dependent Cushing’s syndrome due to intermittent hypercortisolism

ea0011p439 | Endocrine tumours and neoplasia

Hyperprolactinaemia in a series of adults with craniopharyngiomas and Rathke’s cleft cysts: what are the upper limits?

ea0011p440 | Endocrine tumours and neoplasia

Parathyroid scinigraphy for hyperparathyroidism, an assessment of performance

ea0011p441 | Endocrine tumours and neoplasia

Insulinomas – an experience from a tertiary care institution in South India

ea0011p442 | Endocrine tumours and neoplasia

Biological diagnosis of 63 pheochromocytomas and/or paragangliomas

ea0011p443 | Endocrine tumours and neoplasia

Dedifferentiated papillary thyroid cancer. Use of array CGH in searching for prognostic markers

ea0011p444 | Endocrine tumours and neoplasia

Stereotactic conformal radiotherapy in pituitary adenomas – outcome in 36 consecutive patients during years 1996–2004

ea0011p445 | Endocrine tumours and neoplasia

Intra-ovarian adrenocortical carcinoma

ea0011p446 | Endocrine tumours and neoplasia

Comparative efficacy of therapy with sandostatin and parlodel in patients with acromegalia

ea0011p447 | Endocrine tumours and neoplasia

Pituitary tumors in republic of Croatia

ea0011p448 | Endocrine tumours and neoplasia

Histological peculiarities of pituitary adenomas

ea0011p449 | Endocrine tumours and neoplasia

Surgical treatment in acromegaly: predictors of outcome

ea0011p450 | Endocrine tumours and neoplasia

Pituitary mass and hypothyroidism. A case report

ea0011p451 | Endocrine tumours and neoplasia

Incidence rate of thyroid cancer in Olsztyn region in the years 1993–2004

ea0011p452 | Endocrine tumours and neoplasia

A typical clinical picture of four insulinoma cases

ea0011p453 | Endocrine tumours and neoplasia

What is the best glycaemic index for the diagnostic of insulinoma?

ea0011p454 | Endocrine tumours and neoplasia

Sustained correction of hypercortisolism with a low dose mitotane regimen in a young woman with PPNAD and Carney Complex

ea0011p455 | Endocrine tumours and neoplasia

Hypocorticism after radiosurgery (protonotherapy) in patients with normal MRI and in patients with confirmed tumor for Cushing’s disease

ea0011p456 | Endocrine tumours and neoplasia

Prognostic value of KI-67 expression in the cytologic identification of pancreatic endocrine tumors: preliminary data

ea0011p457 | Endocrine tumours and neoplasia

Difficulties in diagnosing persistent acromegaly using current consensus criteria for cure after transsphenoidal surgery

ea0011p458 | Endocrine tumours and neoplasia

Carbohydrate metabolism in patients with hypercorticism

ea0011p459 | Endocrine tumours and neoplasia

Role of family history for diabetes mellitus in determining insulin resistance in acromegalic patients

ea0011p460 | Endocrine tumours and neoplasia

Familial acromegaly

ea0011p461 | Endocrine tumours and neoplasia

Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro

ea0011p462 | Endocrine tumours and neoplasia

Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2

ea0011p463 | Endocrine tumours and neoplasia

An intrasellar germinoma with normal cerebrospinal fluid β-HCG concentration misdiagnosed as hypophysitis

ea0011p464 | Endocrine tumours and neoplasia

Response to medical treatment in male macroprolactinomas

ea0011p465 | Endocrine tumours and neoplasia

Non functioning pituitary tumors

ea0011p466 | Endocrine tumours and neoplasia

Diabetic retinopathy in acromegaly

ea0011p467 | Endocrine tumours and neoplasia

Malignant catecholamine-secreting paragangliomas of retrocardial localization

ea0011p468 | Endocrine tumours and neoplasia

Short-term evaluation of quality of life in acromegalic patients

ea0011p469 | Endocrine tumours and neoplasia

Octreotide as alternative to surgically adrenalectomy

ea0011p470 | Endocrine tumours and neoplasia

Inhibition of IGF-II signal transduction improves chemosensitivity in human adrenocortical cancer cells

ea0011p471 | Endocrine tumours and neoplasia

The new TNM classification is inferior to the Lee classification in predicting outcome in patients with adrenocortical carcinoma

ea0011p472 | Endocrine tumours and neoplasia

Stimulated and spontaneous growth hormone release in irradiated acromegalic patients

ea0011p473 | Endocrine tumours and neoplasia

WNT4 expression in normal human adrenals and adrenocortical tumours

ea0011p474 | Endocrine tumours and neoplasia

The clinical particularities, medical possibility of prolactonomas in men

ea0011p475 | Endocrine tumours and neoplasia

Management of thyroid cancer in children

ea0011p476 | Endocrine tumours and neoplasia

Diagnosis difficulties in insulinomas

ea0011p477 | Endocrine tumours and neoplasia

Insulin-like growth factor-i signalling in tamoxifen sensitive and tamoxifen resistant breast cancer cells

ea0011p478 | Endocrine tumours and neoplasia

Functioning adrenocortical carcinoma and the clinical endocrinologist: toxic treatments and poor prognosis

ea0011p479 | Endocrine tumours and neoplasia

Post-operative serum cortisol for prediction of long-term remission from Cushing’s syndrome

ea0011p480 | Endocrine tumours and neoplasia

An in-frame complex germline mutation in the juxtamembrane intracellular domain causing RET activation in familial medullary thyroid carcinoma

ea0011p481 | Endocrine tumours and neoplasia

Macroprolactinoma: 5 cases

ea0011p482 | Endocrine tumours and neoplasia

48 h appears as sufficient duration of fasting in the diagnosis of insulinoma – a single centre experience with 23 cases

ea0011p483 | Endocrine tumours and neoplasia

A case of a patient with differentiated thyroid carcinoma and metastases to the kidneys

ea0011p484 | Endocrine tumours and neoplasia

Development of a non-isotopic immunoassay for the measurement of aldosterone in saliva

ea0011p485 | Endocrine tumours and neoplasia

Thyroid autoimmunity disorders and breast cancer (BC): absence of morphological autoimmune changes in breast malignant tissue

ea0011p486 | Endocrine tumours and neoplasia

Pituicytoma – a case report

ea0011p487 | Endocrine tumours and neoplasia

PTTG promotes a novel VEGF-KDR-ID3 autocrine mitogenic pathway in thyroid cancer

ea0011p488 | Endocrine tumours and neoplasia

Multiple Endocrine Neoplasia Type 1 (MEN 1) is associated with insulin resistance and an increased prevalence of diabetes and impaired fasting glucose

ea0011p489 | Endocrine tumours and neoplasia

Evaluation of a standardized protocol for the collection and storage of adrenal tumor samples – preparation for an European adrenal tumor bank (ENS@T)

ea0011p490 | Endocrine tumours and neoplasia

Value of overnight dexamethasone suppression test (1 mg-dst) in subclinical Cushing’s syndrome

ea0011p491 | Endocrine tumours and neoplasia

Effect of catecholamine uptake inhibition on catecholamine content in human adrenal chromaffin cells and pheochromocytes

ea0011p492 | Endocrine tumours and neoplasia

PTTG binding factor (PBF) can transform cells independently of interaction with PTTG

ea0011p493 | Endocrine tumours and neoplasia

Carney’s complex with acromegaly as the leading clinical condition

ea0011p494 | Endocrine tumours and neoplasia

Daily profiles of aldosterone secretion in primary aldosteronism

ea0011p495 | Endocrine tumours and neoplasia

Analysis of succynyl dehydrogenase (SDH) subunits gene mutations in patients with paragangliomas

ea0011p496 | Endocrine tumours and neoplasia

Neuropeptide Y-Y1 receptors mediate the effects of neuropeptide Y on prostate cancer cell growth

ea0011p497 | Endocrine tumours and neoplasia

Differential expression of neurogenins by human pituitary adenomas

ea0011p498 | Endocrine tumours and neoplasia

Evidence for an attenuated 11 β-hydroxysteroid dehydrogenase type-1 (11βHSD1) response to an inflammatory stimulus in primary cultures of epithelial ovarian cancer

ea0011p499 | Endocrine tumours and neoplasia

Long-term somatostatin analog octreotide treatment in insulinoma patients

ea0011p500 | Endocrine tumours and neoplasia

Development of dopamine agonist resistance and progression from microadenoma to macroadenoma in two women with hyperprolactinaemia

ea0011p501 | Endocrine tumours and neoplasia

The rare RET mutation (insTTCTdelG) at codon 666 is associated with a low penetrance of medullary thyroid carcinoma and pheochromocytoma

ea0011p502 | Endocrine tumours and neoplasia

Use of TRH in addition to CRH stimulation during bilateral inferior petrosal sinus sampling in Cushing’s syndrome – long term experience

ea0011p503 | Endocrine tumours and neoplasia

Glucagonoma syndrome – treatment with intensive insulin and high dose vitamin B

ea0011p504 | Endocrine tumours and neoplasia

Headaches cured by surgery

ea0011p505 | Endocrine tumours and neoplasia

Chromogranin-A in adrenal incidentalomas – marker for tumour secretion

ea0011p506 | Endocrine tumours and neoplasia

A novel germ-line mutation gly321arg in the exon 5 of the ret proto-oncogene detected in a family with familial medullary thyroid carcinoma

ea0011p507 | Endocrine tumours and neoplasia

Contemporary management of macroprolactinomas

ea0011p508 | Endocrine tumours and neoplasia

Cushing’s paraneoplastic syndrome secondary to recurrent ovarian carcinoma

ea0011p509 | Endocrine tumours and neoplasia

Moleculargenetic and clinical characterisation of neurofibromatosis type 1 – associated pheochromocytoma

ea0011p510 | Endocrine tumours and neoplasia

AcroBel: a registry and survey on acromegaly in Belgium

ea0011p511 | Endocrine tumours and neoplasia

The latest safety and efficacy data of patients treated with Pegvisomant

ea0011p512 | Endocrine tumours and neoplasia

Mutation at codon 804 detected in a Greek kindred by screening of the RET gene in patients with medullary thyroid carcinoma

ea0011p513 | Endocrine tumours and neoplasia

A rare RET gene mutation is found in two apparently unrelated Greek kindreds with familial medullary thyroid carcinoma

ea0011p514 | Endocrine tumours and neoplasia

Surgical cure with preserved pituitary function is rare in acromegalic patients. Results from the Preoperative Octreotide Treatment of Acromegaly (POTA) study

ea0011p515 | Endocrine tumours and neoplasia

Different scintigraphic patterns between sympathetic and parasympathetic paragangliomas

ea0011p516 | Endocrine tumours and neoplasia

mRNA expression of somatostatin receptor subtypes in pheochromocytomas/paragangliomas

ea0011p517 | Endocrine tumours and neoplasia

A retrospective review of the effect of pituitary radiotherapy after transsphenoidal surgery for non-functioning pituitary adenomas

ea0011p518 | Endocrine tumours and neoplasia

Biochemical characteristics of ‘silent’ ACTH-secreting pituitary adenomas: Preoperative serum and urine hormone studies

ea0011p519 | Endocrine tumours and neoplasia

Radiotherapy and o,p’-DDD induce an inhibition of growth and interfere in the cell cycle in H295-R adrenocortical cell line

ea0011p520 | Endocrine tumours and neoplasia

Role of PKA regulatory subunit 2B protein on cortisol-secreting adrenocortical cells proliferation

ea0011p521 | Endocrine tumours and neoplasia

Outcome of management of craniopharyngiomas – a contemporary series

ea0011p522 | Endocrine tumours and neoplasia

Anatomo-clinical features in multihormonal prolactinomas

ea0011p523 | Endocrine tumours and neoplasia

Glucocorticoid receptor gene N363S variant in patients with clinically inapparent adrenal adenomas

ea0011p524 | Endocrine tumours and neoplasia

Characteristics and follow up of thyroid cancer in patients with hyperthyroidism

ea0011p525 | Endocrine tumours and neoplasia

Investigation and surgical management of pancreatic neuroendocrine tumours

ea0011p526 | Endocrine tumours and neoplasia

Estrone and cortisol co-secreting adrenocortical carcinoma in a man presenting with hypogonadotrophic hypogonadism and painful gynaecomastia

ea0011p527 | Endocrine tumours and neoplasia

Origin and spread of the SDHD p.Y114C mutation causing head and neck paraganglioma in Trentino, Italy

ea0011p528 | Endocrine tumours and neoplasia

Characterization of familial non-syndromic pheochromocytoma

ea0011p529 | Endocrine tumours and neoplasia

Endostatin and VEGF levels in serum of patients with pituitary tumors

ea0011p530 | Endocrine tumours and neoplasia

18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer

ea0011p531 | Endocrine tumours and neoplasia

Papillary thyroid microcarcinoma: a low risk neoplasia?

ea0011p532 | Endocrine tumours and neoplasia

The value of fluorine-18 fluorodeoxyglucose PET during follow-up of patients with medullary thyroid carcinoma

ea0011p533 | Endocrine tumours and neoplasia

N363S and BclI variants in the glucocorticoid receptor gene and their associations in Cushing’s syndrome and Addison’s disease

ea0011p534 | Endocrine tumours and neoplasia

Novel inactivating mutations in four Italian cases of familial hypocalciuric hypercalcemia

ea0011p535 | Endocrine tumours and neoplasia

Genetic analyses of familial isolated primary hyperparathyroidism: implications for clinical assessment and surgical management

ea0011p536 | Endocrine tumours and neoplasia

Non-pancreatic carcinoid tumours - prognostic value of proliferative index (Ki67%)

ea0011p537 | Endocrine tumours and neoplasia

Somatostatin receptor subtypes 1–5 in pituitary tumors of various etiologies: investigation by immunohistochemistry

ea0011p538 | Endocrine tumours and neoplasia

High performance liquid chromatography (HPLC) in the follow-up of mitotane therapy in a patient with adrenal carcinoma

ea0011p539 | Endocrine tumours and neoplasia

Multiple endocrine neoplasia type 1 and angiomyxoma

ea0011p540 | Endocrine tumours and neoplasia

Novel L30LR heterozygous mutation of the menin gene in a Hungarian MEN 1 family

ea0011p541 | Endocrine tumours and neoplasia

Differences in the presenting biochemical and imaging data in patients with acromegaly caused by pure GH adenomas, adenomas with GH and PRL cell differentiation and plurihormonal adenomas

ea0011p542 | Endocrine tumours and neoplasia

Management of thyrotrophin-secreting adenoma with octreotide therapy

ea0011p543 | Endocrine tumours and neoplasia

Tumor size and gonadotrophin immunoreactivity of pituitary adenomas

ea0011p544 | Endocrine tumours and neoplasia

Carotid arterial intima-media thickness (IMT), a marker of atherosclerosis, does not differ in patients with acromegaly compared to healthy controls

ea0011p545 | Endocrine tumours and neoplasia

Acute biliary tract problems are common on discontinuation of somatostatin analogue (SA) therapy

ea0011p546 | Endocrine tumours and neoplasia

Cell proliferation and outcome of GH-secreting pituitary adenomas

ea0011p547 | Endocrine tumours and neoplasia

Efficacy and safety of high doses of long-acting somatostatin analogues for treatment of well differentiated functioning neuroendocrine tumors

ea0011p548 | Endocrine tumours and neoplasia

Surgical debulking of GH secreting adenomas improves control of acromegaly by lanreotide – a prospective study

ea0011p549 | Endocrine tumours and neoplasia

Diagnostic utility of dexamethazone suppression tests in the work-up of Cushing’s disease

ea0011p550 | Endocrine tumours and neoplasia

Descriptive epidemiology of thyroid cancer occurring in the population living in the Rhône Alpes region: 1998–2004

ea0011p551 | Endocrine tumours and neoplasia

In vitro effects of som230 on primary cultured pheochromocytoma cells

ea0011p552 | Endocrine tumours and neoplasia

Fourier transform infrared spectroscopy (FTIR) of parathyroid pathology

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more